Morinaga Milk Industry Co Ltd
Morinaga Milk Industry is one of the largest dairy product companies in Japan. Morinaga Milk excels in innovative technology and offers various dairy products and other beneficial functional ingredients to customers around the world. Morinaga Milk started research on bifidobacteria in the 1960s, inspired by the fact that bifidobacteria are the predominant bacteria residing in the intestines of breastfed infants. In 1969, Morinaga Milk isolated its flagship strain Bifidobacterium longum BB536 from a healthy breastfed infant. Since then, Morinaga has been conducting original research to contribute to healthy, fruitful lives for all people.
|Primary business activity||Manufacturer: Ingredients / Additives|
|Affiliated categories:||Postbiotics |Probiotics More|
Our Top products
Bifidobacterium longum subsp. longum BB536 (designated as BB536) is one of the most well-established, clinically effective probiotic strains that confers numerous profound beneficial effects on humans. BB536 possesses a proven track record of safety and clinical efficacy in improving gastroi...More info
Bifidobacterium breve is one of the predominant species present in the infant gut and is widely recognized for its beneficial roles in maintaining infant health. B. breve M-16V (designated as M-16V) has emerged as one of the best studied clinically effective probiotic strains that exert posi...More info
Bifidobacterium longum subspecies infantis M-63 is unique among gut bacteria in its immense capacity to utilize human milk oligosaccharide (HMOs), the component that is highly abundant in human breast milk. HMOs offer no direct nutritive value for infants, but they function in shaping a bett...More info